Elutia Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
26
- Stock Symbol
-
ELUT
- Investments
-
1
- Share Price
-
$0.82
- (As of Friday Closing)
Elutia General Information
Description
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Contact Information
Website
www.elutia.comCorporate Office
- 20 Firstfield Road
- Gaithersburg, MD 20878
- United States
Corporate Office
- 20 Firstfield Road
- Gaithersburg, MD 20878
- United States
Elutia Stock Performance
As of 13-Nov-2026, Elutia’s stock price is $0.82. Its current market cap is $36.4M with 44.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.82 | $0.87 | $0.50 - $1.39 | $36.4M | 44.4M | 184K | $1.29 |
Elutia Financials Summary
As of 30-Sep-2026, Elutia has a trailing 12-month revenue of $13.6M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 19,472 | 53,997 | 126,653 | 61,267 |
| Revenue | 13,592 | 12,293 | 14,467 | 24,745 |
| EBITDA | (26,040) | (13,473) | (40,987) | (31,677) |
| Net Income | 54,391 | 53,380 | (53,949) | (37,656) |
| Total Assets | 48,193 | 62,350 | 36,127 | 43,428 |
| Total Debt | 12,984 | 3,942 | 24,014 | 23,952 |
Elutia Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Elutia Comparisons
Industry
Financing
Details
Elutia Competitors (46)
One of Elutia’s 46 competitors is Globus Medical, a Formerly VC-backed company based in Audubon, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| Joerns Healthcare | Private Equity-Backed | Charlotte, NC | ||||
| Philips | Corporation | Amsterdam, Netherlands | ||||
| Spinal Elements | Private Equity-Backed | Carlsbad, CA | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT |
Elutia Signals
Elutia Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Elutia Investments (1)
Elutia’s most recent deal was a Buyout/LBO with Corvivo. The deal was made on 31-May-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Corvivo | 31-May-2017 | Buyout/LBO | Surgical Devices |
Elutia ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
37.35 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Elutia Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Corvivo | Roswell, GA | 2001 |
Elutia FAQs
-
When was Elutia founded?
Elutia was founded in 2015.
-
Where is Elutia headquartered?
Elutia is headquartered in Gaithersburg, MD.
-
What is the size of Elutia?
Elutia has 26 total employees.
-
What industry is Elutia in?
Elutia’s primary industry is Therapeutic Devices.
-
Is Elutia a private or public company?
Elutia is a Public company.
-
What is Elutia’s stock symbol?
The ticker symbol for Elutia is ELUT.
-
What is the current stock price of Elutia?
As of 13-Nov-2026 the stock price of Elutia is $0.82.
-
What is the current market cap of Elutia?
The current market capitalization of Elutia is $36.4M.
-
What is Elutia’s current revenue?
The trailing twelve month revenue for Elutia is $13.6M.
-
Who are Elutia’s competitors?
Globus Medical, Joerns Healthcare, Philips, Spinal Elements, and Spine Wave are some of the 46 competitors of Elutia.
-
What is Elutia’s annual earnings per share (EPS)?
Elutia’s EPS for 12 months was $1.29.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process